Cellebrite DI OverviewLatest common stock for CLBT: $520M.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Cellebrite DI (CLBT) currently reports a common stock of $520M as of June 2021. Use the charts on this page to explore Cellebrite DI's common stock history and peer comparisons.
Cellebrite DI reported $520M in common stock as of June 2021. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $520M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cellebrite DI, and consider following CLBT for alerts when major investors trade the stock.
Cellebrite DI is classified in the Technology sector. On common stock, it currently shows $520M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing CLBT with unrelated industries.
